Delivery Order HHSN261201200018I-HHSN26100003
Award Date
9/20/12
Potential Completion Date
9/19/14
Potential Value
$615K
Federal Agency
National Cancer Institute
Ultimate Awardee
Cornell University
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10065, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Weill Medical College of Cornell University, a private research university. The $679,923 firm-fixed-price contract is a delivery order under the NCI's larger "PREVENT Cancer Program (PREVENT)" indefinite delivery contract, which has a ceiling value of $149,995,000. The contract is for research and development in biomedical basic research related to...
This is a definitive cost-no-fee contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute to Weill Medical College of Cornell University, a private research university, for preclinical in vitro and in vivo screening assays to support the development of cancer preventive agents. The contract has a potential value of $36,289,060.27 and a completion date of October 31, 2012. It is not set aside for any specific business type. The...
This federal contract award was made by the National Cancer Institute to Weill Medical College of Cornell University, a prestigious private research university, to provide services related to the testing of combination immuno and chemoprevention strategies for Lynch syndrome gastrointestinal cancer. The contract is a Delivery Order under the PREVENT Cancer Program (PREVENT) Indefinite Delivery Contract (IDC), which has a ceiling value of $149,995,000 and enables Weill Medical College to...
Weill Medical College of Cornell University was awarded a delivery order against the PREVENT Cancer Program (PREVENT) multiple award IDIQ by the National Cancer Institute, an agency of the Department of Health and Human Services. The delivery order has a potential value of $891,983.59 to support the development of a Frameshift Peptide Vaccine for the Prevention of Lynch Syndrome-Associated Gastrointestinal Cancer. No set-aside designation was used for this award. The period of performance is...
The provided information describes a federal contract award to Weill Medical College of Cornell University, a prestigious private research university. The contract, with an award value of $9,437,194.06, is for biomedical research services and is managed by the National Heart, Lung, and Blood Institute, a civilian agency within the National Institutes of Health. The contract is a definitive contract with a cost-no-fee pricing type, indicating it is for the delivery of specific research...
This is a $547,860 delivery order contract awarded by the National Cancer Institute (NCI) of the Department of Health and Human Services (HHS) to The Institute for Cancer Research, a non-profit research organization. The contract is part of the Preclinical Efficacy and Intermediate Endpoint Biomarkers indefinite delivery vehicle, which supports the PREVENT Cancer Preclinical Drug Development Program. Under this 5-year IDIQ, The Institute for Cancer Research provides preclinical efficacy...
This is a firm fixed price delivery order awarded by the Department of the Navy, Bureau of Medicine and Surgery, to Weill Medical College of Cornell University. The contract, valued at $116,481.26, is for the provision of tuition and fees. No set-aside was used. Weill Medical College of Cornell University is a private, non-profit research university focused on biomedical research and medical education. The institution has a strong track record of securing federal funding, particularly through...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, to the Sloan-Kettering Institute for Cancer Research, a non-profit organization. The contract is part of the NCI Cancer Genome Atlas Program and is valued at $174,500.00. It involves the collection of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program. The contract has no set-aside...
This federal contract award was issued by the Bureau of Medicine and Surgery, a defense agency, to Weill Medical College of Cornell University, a private non-profit research university. The $89,805.60 firm fixed-price delivery order contract is for tuition and fees, with a period of performance ending on December 31, 2016. The college is performing the work in New York, NY. Weill Medical College is an experienced federal contractor that has received numerous grant awards from agencies like the...
This firm-fixed price purchase order for $241,990 was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) to The Trustees of Columbia University in the City of New York. The contract supports large-scale data analysis to characterize variations in cancer treatments across the United States to assist the NCI's Division of Cancer Control and Population Sciences. The prime contractor, Columbia University, is...